Immunogen - 股票价格

IMGN

9.07

每天都在变化:

1.34%

每年:

105.67%

物价 天 年
Astellas Pharma 1,738.50 21.00 1.22% 3.45%
AbbVie 107.85 -0.56 -0.52% 23.16%
Agios Pharmaceuticals 48.92 1.41 2.97% 4.57%
Amgen 225.69 -1.35 -0.59% 10.41%
Arena Pharmaceuticals 76.81 -3.27 -4.08% 63.63%
AstraZeneca 6,889.00 9.00 0.13% -7.59%
Bluebird Bio 30.80 0.72 2.39% -56.75%
Bristol-Myers Squibb 61.27 -0.36 -0.58% 3.50%
Cerulean Pharma 1.89 -0.10 -5.03% 65.79%
Dicerna Pharmaceuticals 29.51 0.63 2.18% 50.10%
Emergent BioSolutions 99.30 -2.90 -2.84% 77.13%
Exelixis 22.01 -0.29 -1.30% 17.45%
Five Prime Therapeutics 22.31 -1.12 -4.78% 449.51%
Halozyme Therapeutics 45.01 -1.46 -3.14% 125.16%
Heron Therapeutics 17.68 -0.41 -2.27% -4.23%
Immunogen 9.07 0.12 1.34% 105.67%
Karyopharm Therapeutics 13.19 -0.56 -4.07% -46.55%
Eli Lilly 204.14 -2.33 -1.13% 56.66%
MacroGenics 24.47 -0.48 -1.92% 182.89%
Nektar Therapeutics 23.74 0.12 0.51% 22.18%
Novartis 88.17 0.72 0.82% 5.44%
Pfizer 33.51 -0.18 -0.53% -2.30%
Regeneron Pharmaceuticals 454.86 -8.19 -1.77% -1.45%
Roche Holding 300.95 -0.70 -0.23% -9.05%
Seattle Genetics 153.71 1.16 0.76% 43.12%
Sanofi 45.94 0.03 0.07% -3.71%
Acceleron Pharma 135.85 -4.30 -3.06% 46.60%
Intrexon 8.58 0.38 4.63% 167.29%

物价 天 年
NASDAQ 13358 -230.04 -1.69% 53.83%
Russell 2000 2231 -43.81 -1.93% 50.16%

IMGN:US
资产
现金及等价物
销售成本
当前资产
流动负债
债务
股息收益率
EBIT
EBITDA
EPS每股收益
股本和储备
销售毛利
债务利息支出
贷款资金
市值
净收入
营业费用
营业利润
普通股股本
税前利润
销售收入
销售和管理费用
股票
贸易债权人
应收帐款